Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
emEJqMK1ka9U9UJs
Listen
